CN103483219B - 一种米屈肼二水合物制备方法 - Google Patents
一种米屈肼二水合物制备方法 Download PDFInfo
- Publication number
- CN103483219B CN103483219B CN201310387770.1A CN201310387770A CN103483219B CN 103483219 B CN103483219 B CN 103483219B CN 201310387770 A CN201310387770 A CN 201310387770A CN 103483219 B CN103483219 B CN 103483219B
- Authority
- CN
- China
- Prior art keywords
- resin
- methyl propionate
- strongly basic
- propionate salt
- mildronate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- JFWLFLLRLZSBRA-UHFFFAOYSA-N 3-[(trimethylazaniumyl)amino]propanoate;dihydrate Chemical compound O.O.C[N+](C)(C)NCCC([O-])=O JFWLFLLRLZSBRA-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 239000011347 resin Substances 0.000 claims abstract description 111
- 229920005989 resin Polymers 0.000 claims abstract description 111
- 238000000034 method Methods 0.000 claims abstract description 30
- 125000000129 anionic group Chemical group 0.000 claims description 42
- PVBQYTCFVWZSJK-UHFFFAOYSA-N meldonium Chemical compound C[N+](C)(C)NCCC([O-])=O PVBQYTCFVWZSJK-UHFFFAOYSA-N 0.000 claims description 42
- 229960002937 meldonium Drugs 0.000 claims description 41
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical class CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 claims description 39
- 239000007788 liquid Substances 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000007864 aqueous solution Substances 0.000 claims description 31
- 238000002425 crystallisation Methods 0.000 claims description 31
- 230000008025 crystallization Effects 0.000 claims description 31
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 30
- 239000008213 purified water Substances 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 17
- 150000001768 cations Chemical class 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 229960004756 ethanol Drugs 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 230000002378 acidificating effect Effects 0.000 claims description 10
- 230000006837 decompression Effects 0.000 claims description 10
- 125000003011 styrenyl group Chemical class [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
- 239000003957 anion exchange resin Substances 0.000 claims description 8
- 125000002091 cationic group Chemical group 0.000 claims description 8
- 239000000356 contaminant Substances 0.000 claims description 8
- 239000012065 filter cake Substances 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 241000370738 Chlorion Species 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 2
- 229940006461 iodide ion Drugs 0.000 claims description 2
- 238000010999 medical injection Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 5
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 150000001450 anions Chemical class 0.000 abstract 2
- -1 carbomethoxy groups Chemical group 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 description 16
- 239000000843 powder Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000010792 warming Methods 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 229940017219 methyl propionate Drugs 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229910017053 inorganic salt Inorganic materials 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000004566 IR spectroscopy Methods 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 229960004203 carnitine Drugs 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000003841 chloride salts Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003570 biosynthesizing effect Effects 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 1
- JENQTIUGBLYVIS-UHFFFAOYSA-N CC(N(C)C)C(=O)O.C(C)CC(=O)O Chemical compound CC(N(C)C)C(=O)O.C(C)CC(=O)O JENQTIUGBLYVIS-UHFFFAOYSA-N 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011082 depyrogenation Methods 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- PPQFUDZMTNGHBJ-UHFFFAOYSA-N propanoic acid;dihydrate Chemical compound O.O.CCC(O)=O PPQFUDZMTNGHBJ-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310387770.1A CN103483219B (zh) | 2013-08-31 | 2013-08-31 | 一种米屈肼二水合物制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310387770.1A CN103483219B (zh) | 2013-08-31 | 2013-08-31 | 一种米屈肼二水合物制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103483219A CN103483219A (zh) | 2014-01-01 |
CN103483219B true CN103483219B (zh) | 2015-03-25 |
Family
ID=49823875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310387770.1A Active CN103483219B (zh) | 2013-08-31 | 2013-08-31 | 一种米屈肼二水合物制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103483219B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LV13484B (en) * | 2005-02-25 | 2007-03-20 | Jorge Silva | Method for production of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
WO2009103772A1 (en) * | 2008-02-19 | 2009-08-27 | Grindeks, A Joint Stock Company | Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydrazinium)propionate esters and their use for 3-(2,2,2-trimethylhydrazinium)propionate dihydrate preparation |
EP2128126A1 (en) * | 2008-05-26 | 2009-12-02 | Grindeks, a joint stock company | New process for the preparation of 3-(2,2,2-Trimethylhydrazinium) propionate dihydrate |
-
2013
- 2013-08-31 CN CN201310387770.1A patent/CN103483219B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LV13484B (en) * | 2005-02-25 | 2007-03-20 | Jorge Silva | Method for production of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
WO2009103772A1 (en) * | 2008-02-19 | 2009-08-27 | Grindeks, A Joint Stock Company | Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydrazinium)propionate esters and their use for 3-(2,2,2-trimethylhydrazinium)propionate dihydrate preparation |
EP2128126A1 (en) * | 2008-05-26 | 2009-12-02 | Grindeks, a joint stock company | New process for the preparation of 3-(2,2,2-Trimethylhydrazinium) propionate dihydrate |
Also Published As
Publication number | Publication date |
---|---|
CN103483219A (zh) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103030180A (zh) | 一种高纯硫酸锰的生产方法 | |
CN103408473B (zh) | 一种从扇贝内脏中提取天然牛磺酸的方法 | |
CN107344786B (zh) | 一种紫外线吸收剂uv-531生产废水的处理方法 | |
CN102557970B (zh) | 一种无水甜菜碱的制备方法 | |
CN102028179B (zh) | 一种味精母液精制方法 | |
CN102311441B (zh) | 一种叶绿素铜钠盐的生产方法 | |
CN106748873A (zh) | 一种维生素b5机械研磨固相制备方法 | |
CN102167369B (zh) | 一种降低LiCl中NaCl含量的方法 | |
CN103214597A (zh) | 依诺肝素钠中间体脱色方法 | |
CN102321137A (zh) | 一种腺苷钴胺的制备方法 | |
CN103265444B (zh) | 一种5-氨基乙酰丙酸磷酸盐的结晶方法 | |
CN103483219B (zh) | 一种米屈肼二水合物制备方法 | |
CN102718829A (zh) | 牛磺熊去氧胆酸钠的制备方法 | |
CN104262210B (zh) | 一种从泰妙菌素合成废水中提取对甲苯磺酸钠的方法 | |
CN102391339A (zh) | 一种从好氧发酵液中提取腺苷钴胺的方法 | |
CN104193760A (zh) | 一种利用奈马菌素发酵液提取奈马菌素粗品的方法 | |
CN102041281A (zh) | 一种磷脂酶水解制备甘油磷酸胆碱(gpc)的方法 | |
CN107602434B (zh) | 雨生红球藻来源的虾青素晶体及其制备工艺 | |
CN107286071A (zh) | 一种从胆汁中提取胆红素和胆酸并联产胆固醇、卵磷脂的方法 | |
CN104513156A (zh) | 一种粗均苯三甲酸提纯的方法 | |
CN103626809A (zh) | 一种氨基葡萄糖盐酸盐母液的纯化方法 | |
CN203866227U (zh) | 连续分离纯化氨基酸的系统 | |
WO2014114031A1 (zh) | 一种用于精制表面活性剂的混合溶剂及其纯化方法 | |
CN109987616A (zh) | 一种由磷酸锂直接制备电池级氢氧化锂的方法 | |
CN105837543A (zh) | 一种从发酵液中提取精制曲酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ge Zhengquan Inventor after: Zhao Kun Inventor after: Yang Yanjun Inventor after: Liu Suling Inventor before: Yu Donghai Inventor before: Ge Zhengquan Inventor before: Zhao Kun Inventor before: Yang Yanjun |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YU DONGHAI GE ZHENGQUAN ZHAO KUN YANG YANJUN TO: GE ZHENGQUAN ZHAO KUN YANG YANJUN LIU SULING |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190211 Address after: 253100 Shandong Province Plain of Dezhou City Economic Development Zone north two Ring Road West first northbound Shandong Yunjia Pharmaceutical Co. Ltd. Patentee after: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Address before: 250101 2350 development road, hi tech Development Zone, Ji'nan, Shandong Patentee before: JINAN CHENGHUISHUANGDA CHEMICAL INDUSTRY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of midrohydrazine dihydrate Effective date of registration: 20220616 Granted publication date: 20150325 Pledgee: Shandong Pingyuan Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Registration number: Y2022980007784 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230726 Granted publication date: 20150325 Pledgee: Shandong Pingyuan Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Registration number: Y2022980007784 |